MT-401-OTS
MRKR-21-401-OTS
Phase 1 small_molecule active
Quick answer
MT-401-OTS for Acute Myeloid Leukemia, in Relapse is a Phase 1 program (small_molecule) at Marker Therapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Marker Therapeutics
- Indication
- Acute Myeloid Leukemia, in Relapse
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- active